BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35279741)

  • 1. Apremilast and narrowband ultraviolet B combination therapy suppresses Th17 axis and promotes melanogenesis in vitiligo skin: a randomized, split-body, pilot study in skin types IV-VI.
    Kim HJ; Del Duca E; Pavel AB; Singer GK; Abittan BJ; Chima MA; Kimmel G; Bares J; Baum D; Gagliotti M; Genece J; Chu J; Lebwohl MG; Guttman-Yassky E
    Arch Dermatol Res; 2023 Mar; 315(2):215-221. PubMed ID: 35279741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-body and targeted narrowband ultraviolet B phototherapy effectively stabilize acral vitiligo with negligible repigmentation beyond wrists and ankles: Results from a split-body randomized controlled trial.
    Thind A; Vinay K; Mehta H; Bishnoi A; Kumaran MS; Parsad D
    Photodermatol Photoimmunol Photomed; 2024 Mar; 40(2):e12960. PubMed ID: 38480997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apremilast in Combination with Narrowband UVB in the Treatment of Vitiligo: A 52-Week Monocentric Prospective Randomized Placebo-Controlled Study.
    Khemis A; Fontas E; Moulin S; Montaudié H; Lacour JP; Passeron T
    J Invest Dermatol; 2020 Aug; 140(8):1533-1537.e2. PubMed ID: 32004567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of apremilast and narrowband ultraviolet B light in the treatment of generalized vitiligo in skin phototypes IV to VI: A randomized split-body pilot study.
    Kim HJ; Singer GK; Del Duca E; Abittan BJ; Chima MA; Kimmel G; Bares J; Gagliotti M; Genece J; Chu J; Wilding G; Pavel AB; Guttman-Yassky E; Lebwohl MG
    J Am Acad Dermatol; 2021 Dec; 85(6):1657-1660. PubMed ID: 33440217
    [No Abstract]   [Full Text] [Related]  

  • 5. Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study.
    Asawanonda P; Klahan SO
    Photomed Laser Surg; 2010 Oct; 28(5):679-84. PubMed ID: 20961233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis.
    Li R; Qiao M; Wang X; Zhao X; Sun Q
    Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):22-31. PubMed ID: 27696531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of platelet-rich plasma on the outcome of short-term narrowband-ultraviolet B phototherapy in the treatment of vitiligo: a pilot study.
    Ibrahim ZA; El-Ashmawy AA; El-Tatawy RA; Sallam FA
    J Cosmet Dermatol; 2016 Jun; 15(2):108-16. PubMed ID: 26695436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial.
    Lim HW; Grimes PE; Agbai O; Hamzavi I; Henderson M; Haddican M; Linkner RV; Lebwohl M
    JAMA Dermatol; 2015 Jan; 151(1):42-50. PubMed ID: 25230094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative interventional study of narrowband ultraviolet B alone and narrowband ultraviolet B in combination with microneedling in patients with stable vitiligo.
    Kaur A; Barman KD; Sahoo B; Choudhary P
    Photodermatol Photoimmunol Photomed; 2023 Jul; 39(4):357-363. PubMed ID: 36419200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of carboxytherapy with narrowband-ultraviolet B in the treatment of recalcitrant areas of vitiligo: A randomized clinical trial.
    Farajzadeh S; Yazdanpanah F; Khalili M; Mohammadi S; Iranmanesh B; Aflatoonian M
    Dermatol Ther; 2022 Feb; 35(2):e15229. PubMed ID: 34820974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted broadband ultraviolet b phototherapy produces similar responses to targeted narrowband ultraviolet B phototherapy for vitiligo: a randomized, double-blind study.
    Asawanonda P; Kijluakiat J; Korkij W; Sindhupak W
    Acta Derm Venereol; 2008; 88(4):376-81. PubMed ID: 18709309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
    Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
    J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study.
    Middelkamp-Hup MA; Bos JD; Rius-Diaz F; Gonzalez S; Westerhof W
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):942-50. PubMed ID: 17659004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet B therapy in vitiligo? A left-right comparison study.
    Majid I
    Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):230-4. PubMed ID: 20831696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
    Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
    Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of using fractional CO
    Ghasemloo S; Gauthier Y; Ghalamkarpour F
    J Dermatolog Treat; 2019 Nov; 30(7):697-700. PubMed ID: 30592235
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative efficacy between localized 308-nm excimer light and targeted 311-nm narrowband ultraviolet B phototherapy in vitiligo: A randomized, single-blind comparison study.
    Poolsuwan P; Churee C; Pattamadilok B
    Photodermatol Photoimmunol Photomed; 2021 Mar; 37(2):123-130. PubMed ID: 33047405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo--a multicentre controlled study.
    Casacci M; Thomas P; Pacifico A; Bonnevalle A; Paro Vidolin A; Leone G
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):956-63. PubMed ID: 17659006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of narrow band UVB with or without OMP in stabilization of vitiligo activity in skin photo-types (III-V): A double-blind, randomized, placebo-controlled, prospective, multicenter study.
    Esmat SM; El-Mofty M; Rasheed H; Mostafa WZ; Anbar TS; Abdallah M; Bassiouny D; Abdel-Halim D; Hegazy R; Eid AA; Nassar A; Abdel-Aziz RT; Fawzy MM; Gawdat HI; El Hawary M; Sany I; Shalaby S; Ragab N; Abdel-Gaber RM; Tawfik YM; El-Bassiouny M; El-Husseiny R; Attia MS; Farid C; Genedy RM; Mogawer RM
    Photodermatol Photoimmunol Photomed; 2022 May; 38(3):277-287. PubMed ID: 34726808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of narrow band UVB and topical calcipotriol for the treatment of vitiligo.
    Goktas EO; Aydin F; Senturk N; Canturk MT; Turanli AY
    J Eur Acad Dermatol Venereol; 2006 May; 20(5):553-7. PubMed ID: 16684283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.